Diabetic Neuropathies

Diabetic Neuropathies is the indication for 8 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as: Diabetic Neuropathy · Neuropathy, Diabetic
Classified under: Digestive System Diseases
Endocrine System Diseases
Infections
Musculoskeletal and Connective Tissue Diseases
Nervous System Diseases
Nutritional and Metabolic Diseases
Signs, Symptoms, and General Pathologies
Indicated drugs: Amitriptyline
Botulinum toxin type A
Citalopram
Cyanocobalamin
Desipramine
Diltiazem
Lipoic acid
Pioglitazone

Resolves to

Vocabularies

MeSHM0006162SNOMED CT154683002MedDRA10012680UMLSC0011882

What you can answer from here — as of October 22, 2026

8Indicated drugsWith each drug's targets and mechanism

Listed above

8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

260Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Diabetic Neuropathies share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.